5.6.12. summary evidence recommendations treatment ed. summary evidencelifestyle changes lead ed improvement specific populations.pde5is associated significant improvement erectile function (ef) good overall safety profile.there demonstrated differences among different pde5is terms treatment efficacy.topical/intraurethral alprostadil effective improving ef data still limited.vacuum therapy improve ef wide range treatment satisfaction rate.intracavernous injection alprostadil effective treatment ed; however, relatively high treatment drop-out rates.low-intensity shockwave therapy mild improvement ef among patients vasculogenic ed.intracavernous injections prp led mild improvement ef among patients organic ed, available evidence still insufficient provide recommendation regarding use.bont-a shown improve response rate medical treatment ed patients non-responsive oral injective therapies, data still limited.penile rehabilitation pde5is rp increase chance spontaneous ef recovery.penile prosthesis implantation associated high satisfaction rate among patients ed.there difference terms efficacy safety among different penile implants available surgical approaches used. recommendationsstrength ratingfully inform patients mechanism action phosphodiesterase type 5 inhibitors (pde5is) taken, incorrect use/inadequate information main causes lack response pde5is.strongdirect patient cognitive behaviour therapy psychological approach (include partner), indicated, combined medical treatment maximise treatment outcomes.strongdiscuss patients undergoing active treatment prostate cancer (pca) risk sexual changes erectile dysfunction (ed), including sexual desire reduction, changes orgasm, anejaculation, peyronie like disease penile size changes.stronginitiate lifestyle changes risk factor modification prior to, time as, initiating ed treatments.stronguse pde5is first-line therapy treatment ed.stronguse intracavernous injections alternative first-line therapy well-informed patients second-line therapy.stronguse topical/intra-urethral alprostadil alternative first-line therapy well-informed patients who:do wish suitable oral vasoactive therapy;do wish intracavernous injections;in patients prefer less-invasive therapy.weakuse low-intensity shockwave treatment (li-swt) with/without pde5is patientswith mild vasculogenic ed;as alternative therapy well-informed patients wish suitable oral vasoactive therapy;who vasculogenic ed patients poor responders pde5isweakuse vacuum erection devices well-informed patients requesting non-invasive, drug-free management ed.weakimplant penile prosthesis treatments fail depending upon patient preference. patients fully informed benefits harms associated procedure.strongstart pro-erectile treatments earliest opportunity radical prostatectomy/pelvic surgery curative treatments pca.weak